These simple tools were created to help you enroll your patients in Acadia Connect™ and get them started on their prescription medication.
CONNECT WITH US
Monday through Friday, 8:30 am to 8:30 pm ET
Choose your patient’s medicine, select their insurance type and plan and click “Lookup Formulary.”
This information is intended as a guide. Coverage and costs may differ between private and government insurance plans, and are subject to change. Please check with the health plan to confirm coverage for individual patients.
Please see Indication and Important Safety Information, including Boxed WARNING, below.
Your patient may need authorization to get insurance coverage. Complete the fields, and then submit when enrolling your patient in Acadia Connect.
Here’s a quick list of what you need to know about ICD-10 codes for your patients:
For diagnostic codes in treating Parkinson’s disease (PD) psychosis*:
* Diagnostic codes are not required to complete the NUPLAZID treatment form.
WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS
NUPLAZID is indicated for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis.
Dosage and Administration
Recommended dose: 34 mg capsule taken orally once daily, without titration.
NUPLAZID is available as 34 mg capsules and 10 mg tablets.
Please read the full Prescribing Information, including Boxed WARNING.
NUPLAZID is a registered trademark of Acadia Pharmaceuticals Inc.
1. World Health Organization. International Statistical Classification of Diseases and Related Health Problems, ICD-10 version: 2015. https://icd.who.int/browse10/2015/en#/F02.3. Accessed August 4, 2020.